[Meningococcal vaccines. Global epidemiological situation and strategies for prevention by vaccination]

Irene Rivero Calle1, Carmen Rodriguez-Tenreiro Sánchez1, Federico Martinón-Torres1

  • 1Pediatría Clínica, Infectológica y Traslacional. Departamento de Pediatría, Hospital Clínico Universitario de Santiago, Unidad de Investigación en Vacunas, GENVIP, Instituto de Investigación Sanitaria de Santiago, Santiago de Compostela, La Coruña, España.

Insights

Meningococcal disease, caused by Neisseria meningitidis, presents a significant public health challenge. Immunization is the most effective strategy against this potentially fatal illness, as chemoprophylaxis and eliminating carriers are impractical.

Area of Science:

  • Microbiology
  • Epidemiology
  • Public Health

Background:

  • Neisseria meningitidis (N. meningitidis) is a primary cause of meningitis and septicemia globally.
  • Meningococcal disease is characterized by high mortality and severe sequelae, even with advanced medical care.
  • Current control strategies like chemoprophylaxis have limited impact on overall disease burden.

Purpose of the Study:

  • To evaluate the effectiveness of different strategies for controlling meningococcal disease.
  • To highlight the limitations of chemoprophylaxis and carrier elimination.
  • To advocate for immunization as the primary method for disease prevention.

Main Methods:

  • Review of existing literature on N. meningitidis epidemiology and control.
  • Analysis of the impact of chemoprophylaxis on secondary cases.
  • Assessment of the feasibility of eliminating nasopharyngeal carriers.

Main Results:

  • Secondary cases account for only 1%-2% of all meningococcal disease cases.
  • Chemoprophylaxis has a minimal effect on endemic and epidemic forms of the disease.
  • Nasopharyngeal carriage rates of 5%-15% in children and young adults make carrier elimination unfeasible.

Conclusions:

  • Chemotherapeutic elimination of nasopharyngeal colonization is not a viable strategy.
  • Immunization remains the only rational and effective approach to combat meningococcal disease.
  • Vaccination is crucial for reducing the incidence and impact of meningitis and septicemia.

Related Concept Videos

Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
151
Vaccinations01:51

Vaccinations

Overview
54.6K
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable...
67
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
143
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
57
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K